This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1980.
Company Filing History:
Years Active: 1980
Title: The Innovations of Hans U Siebeneick
Introduction
Hans U Siebeneick is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that may aid in treating cardiac insufficiency. His work exemplifies the intersection of innovation and practical application in healthcare.
Latest Patents
Hans U Siebeneick holds a patent for 4,5-Methano-bufadienolide-rhamnosides, which includes their preparation and potential use in pharmaceuticals. This patent describes compounds of the formula I, where R.sup.1 can be hydrogen or an alkyl or acyl group with 1 to 4 carbon atoms. Additionally, R.sup.2 and R.sup.3 can be hydrogen or similar alkyl or acyl groups, or they may combine to form a specific structure involving R.sup.4 and R.sup.5. The innovative compounds he developed may serve as a therapeutic option for counteracting cardiac insufficiency. He has 1 patent to his name.
Career Highlights
Hans U Siebeneick is associated with BASF Aktiengesellschaft, a leading chemical company known for its commitment to innovation and sustainability. His role at BASF has allowed him to engage in cutting-edge research and development, contributing to advancements in medicinal chemistry.
Collaborations
Throughout his career, Hans has collaborated with esteemed colleagues such as Hans P Albrecht and Manfred Raschack. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
Hans U Siebeneick's contributions to the field of medicinal chemistry, particularly through his patent on 4,5-Methano-bufadienolide-rhamnosides, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire future advancements in the industry.